We are live on
!
Find out more
HHAA
Henry H. Armstrong Associates Portfolio holdings
AUM
$1.03B
1-Year Est. Return
4.23%
This Fund
S&P 500
This Quarter
Est. Return
+6.13%
1 Year Est. Return
+4.23%
3 Year Est. Return
+49.29%
5 Year Est. Return
+75.36%
10 Year Est. Return
+299.63%
AUM
$1.03B
AUM Growth
+$51.2M
(+5.2%)
Cap. Flow
+$915K
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
87.66%
Holding
65
New
4
Increased
12
Reduced
22
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$3.11M |
| 2 |
Air Products & Chemicals
APD
|
+$1.51M |
| 3 |
RB Global
RBA
|
+$1.46M |
| 4 |
Donaldson
DCI
|
+$1.13M |
| 5 |
ASML
ASML
|
+$888K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$2.88M |
| 2 |
Microsoft
MSFT
|
+$2.44M |
| 3 |
ExxonMobil
XOM
|
+$1.3M |
| 4 |
Uber
UBER
|
+$753K |
| 5 |
Apple
AAPL
|
+$501K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.95% |
| 2 | Technology | 27.01% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Staples | 6.39% |
| 5 | Industrials | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
McCormick & Company Non-Voting
MKC
$13.7B
| $368K | 0.04% |
7,303
-4,360
| -37% | -$214K |
|
|
NVO
52
Novo Nordisk
NVO
$208B
| $319K | 0.03% |
6,664
| – | – |
|
53
iShares Core S&P 500 ETF
IVV
$878B
| $312K | 0.03% |
417
| – | – |
|
54
RTX Corp
RTX
$290B
| $303K | 0.03% |
1,598
| – | – |
|
55
Vanguard S&P 500 ETF
VOO
$979B
| $287K | 0.03% |
418
+79
| +23% | +$52.7K |
|
56
Chevron
CVX
$392B
| $245K | 0.02% |
1,478
-100
| -6% | -$18.6K |
|
57
Solventum
SOLV
$14.8B
| $245K | 0.02% |
3,175
| – | – |
|
58
Merck
MRK
$322B
| $237K | 0.02% |
1,843
| – | – |
|
59
Tesla
TSLA
$1.23T
| $225K | 0.02% |
+534
| New | +$212K |
|
60
GE HealthCare
GEHC
$30.7B
| $223K | 0.02% |
3,489
| – | – |
|
61
Cisco
CSCO
$457B
| $223K | 0.02% |
+1,897
| New | +$198K |
|
62
STMicroelectronics
STM
$46.7B
| $221K | 0.02% |
+2,950
| New | +$177K |
|
63
Bausch Health
BHC
$2.58B
| $218K | 0.02% |
44,215
| – | – |
|
|
NXDR
64
Nextdoor Holdings
NXDR
$847M
| $23.2K | ﹤0.01% |
10,209
| – | – |
|
|
65
ExxonMobil
XOM
$644B
| – | – |
-7,657
| Closed | -$1.3M |
|
Similar funds
RIM
JSC
WHCM
CM
CFFNO
TBA
SB
MSIIA
Henry H. Armstrong Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Henry H. Armstrong Associates held 65 positions worth $1.03B, up 5.2% from $981M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Henry H. Armstrong Associates's Q2 2026 filing shows 4 new, 12 increased, 22 reduced and 1 closed positions. Its largest new stake was Advanced Micro Devices: 900 shares worth $523K. The largest sale was Berkshire Hathaway Class A, an estimated $2.88M.
By sector, the portfolio is most concentrated in Financials at 45% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
- Henry H. Armstrong Associates's largest Q2 2026 buy was Advanced Micro Devices: 900 shares worth $523K.
- Henry H. Armstrong Associates added most to Berkshire Hathaway Class B in Q2 2026, an estimated $3.11M increase.
- Henry H. Armstrong Associates's biggest Q2 2026 reduction was Berkshire Hathaway Class A, cutting an estimated $2.88M.
- Henry H. Armstrong Associates fully exited ExxonMobil in Q2 2026, selling an estimated $1.3M.
- Henry H. Armstrong Associates's ten largest holdings make up 88% of its $1.03B portfolio in Q2 2026.
- Henry H. Armstrong Associates opened 4 new positions and closed 1 in Q2 2026.
- Henry H. Armstrong Associates's portfolio value rose 5.2% quarter-over-quarter to $1.03B.
Based on Henry H. Armstrong Associates's 13F filing for Q2 2026, filed 7 Jul 2026.